Treatment with the HSL inhibitor was also performed for 2 wk in 6-wk-old Leprdb/Leprdb mice that carry homozygous mutation of the leptin receptor and are genetically prone to obesity and diabetes. The gene discussed is LEPR; the disease is obesity disorder.